A short in-frame deletion in NTRK1 tyrosine kinase domain caused by a novel splice site mutation in a patient with congenital insensitivity to pain with anhidrosis
详细信息 查看全文
- 作者：Esther Sarasola (1)
Jose A Rodríguez (2)
Elisa Garrote (3)
Javier Arístegui (3)
Maria J García-Barcina (1) - 刊名：BMC Medical Genetics
- 出版年：2011
- 出版时间：December 2011
- 年：2011
- 卷：12
- 期：1
- 全文大小：296KB
- 参考文献：1. Swanson AG: Congenital insensitivity to pain with anhydrosis. A unique syndrome in two male siblings. / Arch Neurol 1963, 8:299-06.
2. Axelrod FB, Chelimsky GG, Weese-Mayer DE: Pediatric autonomic disorders. / Pediatrics 2006, 118:309-21. CrossRef
3. Nolano M, Crisci C, Santoro L, Barbieri F, Casale R, Kennedy WR, Wendelschafer-Crabb G, Provitera V, Di Lorenzo N, Caruso G: Absent innervation of skin and sweat glands in congenital insensitivity to pain with anhidrosis. / Clin Neurophysiol 2000, 111:1596-601. CrossRef
4. Verpoorten N, De Jonghe P, Timmerman V: Disease mechanisms in hereditary sensory and autonomic neuropathies. / Neurobiol Dis 2006, 21:247-55. CrossRef
5. Indo Y: Nerve growth factor, interoception, and sympathetic neuron: lesson from congenital insensitivity to pain with anhidrosis. / Auton Neurosci 2009, 147:3-. CrossRef
6. Indo Y, Tsuruta M, Hayashida Y, Karim MA, Ohta K, Kawano T, Mitsubuchi H, Tonoki H, Awaya Y, Matsuda I: Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. / Nat Genet 1996, 13:485-88. CrossRef
7. Martin-Zanca D, Oskam R, Mitra G, Copeland T, Barbacid M: Molecular and biochemical characterization of the human trk proto-oncogene. / Mol Cell Biol 1989, 9:24-3.
8. Levi-Montalcini R: The nerve growth factor 35 years later. / Science 1987, 237:1154-162. CrossRef
9. Beigelman A, Levy J, Hadad N, Pinsk V, Haim A, Fruchtman Y, Levy R: Abnormal neutrophil chemotactic activity in children with congenital insensitivity to pain with anhidrosis (CIPA): the role of nerve growth factor. / Clin Immunol 2009, 130:365-72. CrossRef
10. Mardy S, Miura Y, Endo F, Matsuda I, Sztriha L, Frossard P, Moosa A, Ismail EA, Macaya A, Andria G, Toscano E, Gibson W, Graham GE, Indo Y: Congenital insensitivity to pain with anhidrosis: novel mutations in the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor. / Am J Hum Genet 1999, 64:1570-579. CrossRef
11. Miura Y, Mardy S, Awaya Y, Nihei K, Endo F, Matsuda I, Indo Y: Mutation and polymorphism analysis of the TRKA (NTRK1) gene encoding a high-affinity receptor for nerve growth factor in congenital insensitivity to pain with anhidrosis (CIPA) families. / Hum Genet 2000, 106:116-24. CrossRef
12. Bodzioch M, Lapicka K, Aslanidis C, Kacinski M, Schmitz G: Two novel mutant alleles of the gene encoding neurotrophic tyrosine kinase receptor type 1 (NTRK1) in a patient with congenital insensitivity to pain with anhidrosis: a splice junction mutation in intron 5 and cluster of four mutations in exon 15. / Hum Mutat 2001, 17:72. CrossRef
13. Indo Y, Mardy S, Miura Y, Moosa A, Ismail EA, Toscano E, Andria G, Pavone V, Brown DL, Brooks A, Endo F, Matsuda I: Congenital insensitivity to pain with anhidrosis (CIPA): novel mutations of the TRKA (NTRK1) gene, a putative uniparental disomy, and a linkage of the mutant TRKA and PKLR genes in a family with CIPA and pyruvate kinase deficiency. / Hum Mutat 2001, 18:308-18. CrossRef
14. Bonkowsky JL, Johnson J, Carey JC, Smith AG, Swoboda KJ: An infant with primary tooth loss and palmar hyperkeratosis: a novel mutation in the NTRK1 gene causing congenital insensitivity to pain with anhidrosis. / Pediatrics 2003, 112:e237-41. CrossRef
15. Verpoorten N, Claeys KG, Deprez L, Jacobs A, Van Gerwen V, Lagae L, Arts WF, De Meirleir L, Keymolen K, Ceuterick-de Groote C, De Jonghe P, Timmerman V, Nelis E: Novel frameshift and splice site mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with hereditary sensory neuropathy type IV. / Neuromuscul Disord 2006, 16:19-5. CrossRef
16. Huehne K, Zweier C, Raab K, Odent S, Bonnaure-Mallet M, Sixou J, Landrieu P, Goizet C, Sarlangue J, Baumann M, Eggermann T, Rauch A, Ruppert S, Stettner GM, Rautenstrauss B: Novel missense, insertion and deletion mutations in the neurotrophic tyrosine kinase receptor type 1 gene (NTRK1) associated with congenital insensitivity to pain with anhidrosis. / Neuromuscul Disord 2008, 18:159-66. CrossRef
17. Tüysüz B, Bayrakli F, DiLuna ML, Bilguvar K, Bayri Y, Yalcinkaya C, Bursali A, Ozdamar E, Korkmaz B, Mason CE, Ozturk AK, Lifton RP, State MW, Gunel M: Novel NTRK1 mutations cause hereditary sensory and autonomic neuropathy type IV: demonstration of a founder mutation in the Turkish population. / Neurogenetics 2008, 9:119-25. CrossRef
18. Suriu C, Khayat M, Weiler M, Kfir N, Cohen C, Zinger A, Aslanidis C, Schmitz G, Falik-Zaccai TC: Skoura - a genetic island for congenital insensitivity to pain and anhidrosis among Moroccan Jews, as determined by a novel mutation in the NTRK1 gene. / Clin Genet 2009, 75:230-36. CrossRef
19. Lee S, Lee J, Lee M, Kim J, Ki C: Clinical and genetic analysis of Korean patients with congenital insensitivity to pain with anhidrosis. / Muscle Nerve 2009, 40:855-59. CrossRef
20. Nicholson P, Yepiskoposyan H, Metze S, Zamudio Orozco R, Kleinschmidt N, Mühlemann O: Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. / Cell Mol Life Sci 2010, 67:677-00. CrossRef
21. Mardy S, Miura Y, Endo F, Matsuda I, Indo Y: Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor. / Hum Mol Genet 2001, 10:179-88. CrossRef
22. Miranda C, Di Virgilio M, Selleri S, Zanotti G, Pagliardini S, Pierotti MA, Greco A: Novel pathogenic mechanisms of congenital insensitivity to pain with anhidrosis genetic disorder unveiled by functional analysis of neurotrophic tyrosine receptor kinase type 1/nerve growth factor receptor mutations. / J Biol Chem 2002, 277:6455-462. CrossRef
23. Miranda C, Selleri S, Pierotti MA, Greco A: The M581V mutation, associated with a mild form of congenital insensitivity to pain with anhidrosis, causes partial inactivation of the NTRK1 receptor. / J Invest Dermatol 2002, 119:978-79. CrossRef
24. Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA: Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. / N Engl J Med 2004, 350:2129-139. CrossRef
25. Miranda C, Zanotti G, Pagliardini S, Ponzetto C, Pierotti MA, Greco A: Gain of function mutations of RTK conserved residues display differential effects on NTRK1 kinase activity. / Oncogene 2002, 21:8334-339. CrossRef
26. Freeman R: Autonomic peripheral neuropathy. / Lancet 2005, 365:1259-270. CrossRef
27. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/12/86/prepub - 作者单位：Esther Sarasola (1)
Jose A Rodríguez (2)
Elisa Garrote (3)
Javier Arístegui (3)
Maria J García-Barcina (1)
1. Department of Genetics, Basurto University Hospital (OSAKIDETZA/Servicio Vasco de Salud), Bilbao, Spain
2. Departament of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Leioa, Spain
3. Department of Pediatrics, Basurto University Hospital (OSAKIDETZA/Servicio Vasco de Salud), Bilbao, Spain - ISSN：1471-2350
文摘
Background Congenital insensitivity to pain with anhidrosis (CIPA) is a rare autosomal recessive genetic disease characterized by the lack of reaction to noxious stimuli and anhidrosis. It is caused by mutations in the NTRK1 gene, which encodes the high affinity tyrosine kinase receptor I for Neurotrophic Growth Factor (NGF). Case Presentation We present the case of a female patient diagnosed with CIPA at the age of 8 months. The patient is currently 6 years old and her psychomotor development conforms to her age (RMN, SPECT and psychological study are in the range of normality). PCR amplification of DNA, followed by direct sequencing, was used to investigate the presence of NTRK1 gene mutations. Reverse transcriptase (RT)-PCR amplification of RNA, followed by cloning and sequencing of isolated RT-PCR products was used to characterize the effect of the mutations on NTRK1 mRNA splicing. The clinical diagnosis of CIPA was confirmed by the detection of two splice-site mutations in NTRK1, revealing that the patient was a compound heterozygote at this gene. One of these alterations, c.574+1G>A, is located at the splice donor site of intron 5. We also found a second mutation, c.2206-2 A>G, not previously reported in the literature, which is located at the splice acceptor site of intron 16. Each parent was confirmed to be a carrier for one of the mutations by DNA sequencing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping during NTRK1 mRNA splicing. We could confirm this prediction and, more importantly, we provide evidence that the novel c.2206-2A>G mutation also disrupts normal NTRK1 splicing, leading to the use of an alternative splice acceptor site within exon 17. As a consequence, this mutation would result in the production of a mutant NTRK1 protein with a seven aminoacid in-frame deletion in its tyrosine kinase domain. Conclusions We present the first description of a CIPA-associated NTRK1 mutation causing a short interstitial deletion in the tyrosine kinase domain of the receptor. The possible phenotypical implications of this mutation are discussed.